Osteora
Osteora
Explore our certified trauma, joint reconstruction, and sports medicine implant devices designed for clinical durability and biomechanical stability.
Architecting medical-grade precision implants backed by rigorous testing, advanced metallurgy, and certified ISO 13485 quality systems.
Osteora Medical Devices Co., Ltd. is a professional orthopedic implant and surgical solution manufacturer specializing in trauma, spine, and joint reconstruction systems under the brand Osteora.
Founded in 2016, the company has developed a strong reputation in the global orthopedic industry through continuous innovation and strict quality control standards. The facility covers an area of approximately 18,500㎡, supporting integrated production, assembly, and testing operations.
With 8 years of export experience and 12 years of industry expertise, Osteora has established stable cooperation with international distributors and hospitals across multiple regions. Annual export revenue ranges from USD 6 million to 14 million, reflecting steady global market growth.
The company implements comprehensive quality assurance systems, including ISO 13485 compliance, in-process inspection, and final random sampling testing. Product inspection methods include dimensional measurement, mechanical fatigue testing, and biocompatibility validation. The quality control team consists of 42 specialized inspectors ensuring strict adherence to international medical device standards.
Osteora has a strong trade background in global medical device export and maintains long-term partnerships with distributors in Europe, Southeast Asia, the Middle East, and South America, which are also its primary markets.
The company’s supply chain includes approximately 1,200 certified upstream and downstream partners, supporting stable production capacity and reliable delivery performance. Its main customer base consists of hospitals, orthopedic clinics, surgical centers, and medical distributors.
With strong R&D capabilities, Osteora operates an in-house engineering team of 85 R&D engineers, focusing on innovation in trauma fixation systems, spinal implants, and joint reconstruction technologies. The company offers extensive customization options, including OEM/ODM services, size variations, material customization, and private labeling.
In the past year, Osteora launched approximately 120 new products, reflecting its continuous investment in innovation and product development to meet evolving clinical needs.
Analyzing clinical shifts from rigid tibiotalar fusion to anatomical motion preservation and complex distal tibia reconstructive systems.
Inside Osteora’s 18,500㎡ state-of-the-art facility: From raw material validation to cleanroom sterile packaging.
Executing zero-defect manufacturing through multi-axis CNC lathe centers, automated optical measurement, and specialized laser technology.
42 full-time QA/QC inspectors utilizing advanced mechanical, chemical, and physical validation equipment to guarantee lifetime reliability.
Engineering orthopedic-grade devices engineered for extreme cyclical load-bearing conditions in lower extremity kinematics.
Ankle implants endure intense mechanical stress—up to five times total body weight during normal gait cycles. Osteora utilizes premium Titanium Grade 5 ELI (Extra Low Interstitial), offering optimal fracture toughness, superior fatigue strength, and low elastic modulus close to human cortical bone. This significantly mitigates stress shielding and minimizes post-operative osteolysis.
For suture anchors used in foot and ankle ligament repairs, non-absorbable PEEK biopolymers provide radiolucency (allowing artifact-free MRI/CT imaging post-surgery) alongside biocompatibility and stiffness comparable to native cancellous bone structures.
Total ankle prostheses articulation requires flawless sliding interfaces. Osteora's CoCrMo femoral components undergo vacuum arc remelting and precision mirror polishing to achieve a surface roughness ($Ra$) of less than 0.01 $\mu m$, dramatically lowering ultra-high-molecular-weight polyethylene (UHMWPE) wear debris creation.
Empowering hospital groups, surgical distribution networks, and medical device brand owners with turnkey custom manufacturing.
Pioneering 3D porous titanium additive manufacturing, patient-specific cutting guides, and bio-resorbable anchor matrices.
Osteora is scaling electron beam melting (EBM) additive manufacturing to produce customizable total ankle implants featuring biomimetic interconnected porosity. This pore structure (pore size 300–600 $\mu m$, porosity 60–70%) mimics human cancellous bone to promote immediate vascularization and long-term osseointegration without structural delamination risks associated with traditional plasma spray coatings.
Integrating patient CT DICOM data with automated AI segmentation algorithms allows the pre-operative generation of customized resection guides. This surgical approach minimizes bone loss, reduces surgical time by up to 25%, and ensures optimal prosthetic alignment relative to the mechanical axis of the lower leg.
Next-generation clinical solutions under R&D incorporate micro-arc oxidation (MAO) enriched with hydroxyapatite (HA) and silver ions ($Ag^+$), mitigating surgical site infections (SSI) while accelerating primary bone attachment in osteopenic patients.
Comprehensive answers regarding certification, manufacturing capacities, quality control, and international logistics.
Explore our comprehensive selection of orthopedic screws, locking plates, intramedullary nails, and total joint components.
